PharmaCom BioVet, Inc. has announced that the company has located its first initial location to begin the full-scale build out of the nation's first branded, dedicated Veterinary Oncology Treatment Center.
The initial centre is intended to be located at the Missouri Information Center located at the University of Missouri Life Science Business Incubator at Monsanto Place. The lease will be finalized within the next thirty days.
According to Sharon Berthold, executive vice president of PharmaCom BioVet, Inc., "Plans are underway to build and fully staff PharmaCom BioVet's first treatment centre with some of the nations top veterinary oncologists. The company also plans to collaborate with partner firms, which are also located at Monsanto Place, to offer specialized care for companion animals suffering from all forms of cancer. A sales staff will be hired to market its niche Veterinary Oncology Treatment Centers to local non-specialized veterinarians. A marketing campaign will be initiated locally and commercials will be filmed and aired on local cable television. We expect to begin a rapid build out of our branded Veterinary Oncology Treatment Centers shortly after the opening of this flagship location."
PharmaCom BioVet, Inc. (PHMB) is quickly positioning itself to becoming the leader in specialized veterinary oncology (cancer treatment facilities for animals). PHMB management is planning the rollout of specialized Veterinary Oncology Treatment Centers that will be strategically located throughout the United States. PHMB has licensed a series of proprietary devices and compounds that will enable animals suffering from cancer a greater life expectancy and decreased suffering.